Skip to Content
주식/증권 📉 부정적

Hims Insider Makes First Stock Purchase Since 2021 Amid Weight-Loss Drug Pivot

요약

Hims & Hers Health shares have slumped in 2026 as the telehealth provider moves away from selling compounded GLP-1 medications.